ERBB2 and invasive ductal breast carcinoma: There was no skin invasion, and core needle biopsy revealed invasive ductal carcinoma cT2N1M0 cStage IIB, estrogen receptor (+)/progesterone receptor (+)/HER2/neu (–)/Ki-67 labeling index: 27.8%.